Report Detail
Global (United States, European Union and China) Meningococcal Disease Treatment Market Research Report 2019-2025
- RnM3578900 |
- 08 July, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
Meningococcal disease is a severe infection of meninges, the thin layers of tissue covering brain and spinal cord, caused by the bacteria Neisseria meningitidis. This bacteria can also cause bloodstream infections (septicemia). Bacterial meningitis is severe because of rapid onset and a significant risk of death associated with infection. Infection of Neisseria meningitidis may also result in mental retardation, deafness and epilepsy. 12 strains of N. meningitidis have been identified, 6 of which (A, B, C, W, X and Y) are capable enough to cause epidemics. Meningococcal septicaemia is a rare but fatal form of meningococcal disease characterized by a haemorrhagic rash and rapid circulatory collapse.
In 2019, the market size of Meningococcal Disease Treatment is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Meningococcal Disease Treatment.
This report studies the global market size of Meningococcal Disease Treatment, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Meningococcal Disease Treatment sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Pfizer
GlaxoSmithKline
Sanofi Pasteur
Novartis
...
Market Segment by Product Type
Antibiotics
Vaccines
Market Segment by Application
Hospitals
Drugstores
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Meningococcal Disease Treatment status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Meningococcal Disease Treatment manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Meningococcal Disease Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Meningococcal Disease Treatment Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Antibiotics
- 1.3.3 Vaccines
- 1.4 Market Segment by Application
- 1.4.1 Global Meningococcal Disease Treatment Market Share by Application (2019-2025)
- 1.4.2 Hospitals
- 1.4.3 Drugstores
- 1.4.4 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Meningococcal Disease Treatment Market Size
- 2.1.1 Global Meningococcal Disease Treatment Revenue 2014-2025
- 2.1.2 Global Meningococcal Disease Treatment Sales 2014-2025
- 2.2 Meningococcal Disease Treatment Growth Rate by Regions
- 2.2.1 Global Meningococcal Disease Treatment Sales by Regions 2014-2019
- 2.2.2 Global Meningococcal Disease Treatment Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Meningococcal Disease Treatment Sales by Manufacturers
- 3.1.1 Meningococcal Disease Treatment Sales by Manufacturers 2014-2019
- 3.1.2 Meningococcal Disease Treatment Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Meningococcal Disease Treatment Revenue by Manufacturers (2014-2019)
- 3.2.2 Meningococcal Disease Treatment Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Meningococcal Disease Treatment Market Concentration Ratio (CR5 and HHI)
- 3.3 Meningococcal Disease Treatment Price by Manufacturers
- 3.4 Key Manufacturers Meningococcal Disease Treatment Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Meningococcal Disease Treatment Market
- 3.6 Key Manufacturers Meningococcal Disease Treatment Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Antibiotics Sales and Revenue (2014-2019)
- 4.1.2 Vaccines Sales and Revenue (2014-2019)
- 4.2 Global Meningococcal Disease Treatment Sales Market Share by Type
- 4.3 Global Meningococcal Disease Treatment Revenue Market Share by Type
- 4.4 Meningococcal Disease Treatment Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Meningococcal Disease Treatment Sales by Application
6 United States
- 6.1 United States Meningococcal Disease Treatment Breakdown Data by Company
- 6.2 United States Meningococcal Disease Treatment Breakdown Data by Type
- 6.3 United States Meningococcal Disease Treatment Breakdown Data by Application
7 European Union
- 7.1 European Union Meningococcal Disease Treatment Breakdown Data by Company
- 7.2 European Union Meningococcal Disease Treatment Breakdown Data by Type
- 7.3 European Union Meningococcal Disease Treatment Breakdown Data by Application
8 China
- 8.1 China Meningococcal Disease Treatment Breakdown Data by Company
- 8.2 China Meningococcal Disease Treatment Breakdown Data by Type
- 8.3 China Meningococcal Disease Treatment Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Meningococcal Disease Treatment Breakdown Data by Company
- 9.2 Rest of World Meningococcal Disease Treatment Breakdown Data by Type
- 9.3 Rest of World Meningococcal Disease Treatment Breakdown Data by Application
- 9.4 Rest of World Meningococcal Disease Treatment Breakdown Data by Countries
- 9.4.1 Rest of World Meningococcal Disease Treatment Sales by Countries
- 9.4.2 Rest of World Meningococcal Disease Treatment Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Pfizer
- 10.1.1 Pfizer Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Meningococcal Disease Treatment
- 10.1.4 Meningococcal Disease Treatment Product Introduction
- 10.1.5 Pfizer Recent Development
- 10.2 GlaxoSmithKline
- 10.2.1 GlaxoSmithKline Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Meningococcal Disease Treatment
- 10.2.4 Meningococcal Disease Treatment Product Introduction
- 10.2.5 GlaxoSmithKline Recent Development
- 10.3 Sanofi Pasteur
- 10.3.1 Sanofi Pasteur Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Meningococcal Disease Treatment
- 10.3.4 Meningococcal Disease Treatment Product Introduction
- 10.3.5 Sanofi Pasteur Recent Development
- 10.4 Novartis
- 10.4.1 Novartis Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Meningococcal Disease Treatment
- 10.4.4 Meningococcal Disease Treatment Product Introduction
- 10.4.5 Novartis Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Meningococcal Disease Treatment Sales Channels
- 11.2.2 Meningococcal Disease Treatment Distributors
- 11.3 Meningococcal Disease Treatment Customers
12 Market Forecast
- 12.1 Global Meningococcal Disease Treatment Sales and Revenue Forecast 2019-2025
- 12.2 Global Meningococcal Disease Treatment Sales Forecast by Type
- 12.3 Global Meningococcal Disease Treatment Sales Forecast by Application
- 12.4 Meningococcal Disease Treatment Forecast by Regions
- 12.4.1 Global Meningococcal Disease Treatment Sales Forecast by Regions 2019-2025
- 12.4.2 Global Meningococcal Disease Treatment Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Meningococcal Disease Treatment. Industry analysis & Market Report on Meningococcal Disease Treatment is a syndicated market report, published as Global (United States, European Union and China) Meningococcal Disease Treatment Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Meningococcal Disease Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
